351 results on '"Butelman, Eduardo"'
Search Results
2. Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice
3. Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
4. Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model
5. Contributors
6. Addictions
7. Neurobiological Mechanisms in Substance Use
8. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
9. Neuroimmune Mechanisms of Opioid Use Disorder and Recovery: Translatability to Human Studies, and Future Research Directions
10. 470 Associations with gene-transcript expressions in cocaine use disorder reveal genetic predispositions with other substance use and cardio-neurovascular disease.
11. ScISOr-ATAC reveals convergent and divergent splicing and chromatin specificities between matched cell types across cortical regions, evolution, and in Alzheimer's disease.
12. Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders
13. Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice
14. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
15. Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors
16. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat
17. Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions
18. Impact of the COVID-19 Pandemic on Functions of Nursing Professionals in the Care of Opioid Use Disorder: Systematic Review.
19. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
20. 12:00 P.M. - 1:00 P.M - IN MEMORIAM MARY JEANNE KREEK: Plaza Ballroom BCEF (Plenary Ballroom)
21. Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features
22. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
23. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence
24. Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration
25. Overdose mortality rates for opioids or stimulants are higher in males than females, controlling for rates of drug misuse: State-level data
26. Men have approximately 2- to 3-fold greater overdose mortality than women for synthetic opioids, heroin and psychostimulants including cocaine across the lifespan: Analysis of state-level CDC data for 2020-2021
27. “Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats”
28. The effects of an N-methyl-D-aspartate antagonist on behaviour, learning and memory in the rat
29. Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention Data to November 2021
30. Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
31. Can a rapid measure of self‐exposure to drugs of abuse provide dimensional information on depression comorbidity?
32. Semisynthetic neoclerodanes as kappa opioid receptor probes
33. Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.
34. Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions
35. The Widely Available Hallucinogenic Plant Salvia divinorum and Its Main Component, Salvinorin A
36. List of Contributors
37. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population
38. Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice
39. Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6 J mice
40. List of Contributors
41. Addictions
42. Neurobiology of Opiates and Opioids
43. PET Imaging of Leptin Biodistribution and Metabolism in Rodents and Primates
44. Opiate and cocaine addiction: from bench to clinic and back to the bench
45. Additional file 1 of Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
46. Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users
47. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
48. Limited effects of β-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates
49. Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats
50. The discriminative effects of the κ-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.